ROYAL BANK OF CANADA - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q4 2018$0630
+215.0%
0.00%
Q3 2018$0200
-81.5%
0.00%
Q2 2018$0
-100.0%
1,083
+105.1%
0.00%
Q4 2017$1,000
-97.4%
528
-96.2%
0.00%
Q3 2017$39,000
+69.6%
13,860
+47.9%
0.00%
Q2 2017$23,000
+21.1%
9,372
+77.2%
0.00%
Q1 2017$19,000
+5.6%
5,289
+3.6%
0.00%
Q4 2016$18,000
-28.0%
5,107
-16.8%
0.00%
Q3 2016$25,000
+19.0%
6,138
+27.3%
0.00%
Q2 2016$21,000
+23.5%
4,820
+10.2%
0.00%
Q1 2016$17,000
-51.4%
4,373
+96.4%
0.00%
Q4 2015$35,000
+66.7%
2,227
+6.9%
0.00%
Q3 2015$21,000
-77.4%
2,084
-43.5%
0.00%
Q2 2015$93,000
+675.0%
3,687
+743.7%
0.00%
Q1 2015$12,000
-81.0%
437
-87.3%
0.00%
Q4 2014$63,000
+950.0%
3,434
+663.1%
0.00%
Q3 2014$6,000
-75.0%
450
-70.0%
0.00%
Q2 2014$24,000
+300.0%
1,500
+400.0%
0.00%
Q1 2014$6,000
-86.0%
300
-83.3%
0.00%
Q4 2013$43,000
-76.5%
1,800
-65.2%
0.00%
Q3 2013$183,000
+863.2%
5,169
+330.8%
0.00%
Q2 2013$19,0001,2000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q3 2015
NameSharesValueWeighting ↓
TSP Capital Management Group, LLC 813,273$3,286,0001.66%
RTW INVESTMENTS, LP 1,243,164$5,022,0001.52%
Marcus Capital, LLC 112,200$453,0000.44%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 996,178$4,024,0000.29%
Benchmark Capital Advisors 67,000$271,0000.20%
SUFFOLK CAPITAL MANAGEMENT LLC 360,299$1,456,0000.20%
COLUMBIA WANGER ASSET MANAGEMENT LLC 2,907,523$11,746,0000.15%
Virtus ETF Advisers LLC 59,537$241,0000.12%
Bellevue Group AG 160,000$646,0000.12%
PDT Partners, LLC 428,300$1,730,0000.10%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders